358
Views
13
CrossRef citations to date
0
Altmetric
Review

Long-term oxygen therapy

&
Pages 639-649 | Published online: 09 Jan 2014

References

  • Barach AL. The therapeutic use of oxygen. JAMA 79(9), 693–699 (1922).
  • Petty TL. Historical highlights of long-term oxygen therapy. Respir. Care 45(1), 29–36; discussion 36 (2000).
  • Levine BE, Bigelow DB, Hamstra RD et al. The role of long-term continuous oxygen administration in patients with chronic airway obstruction with hypoxemia. Ann. Intern. Med. 66(4), 639–650 (1967).
  • Petty TL, Finigan MM. Clinical evaluation of prolonged ambulatory oxygen therapy in chronic airway obstruction. Am. J. Med. 45(2), 242–252 (1968).
  • McDonald CF, Crockett AJ, Young IH. Adult domiciliary oxygen therapy. Position statement of the Thoracic Society of Australia and New Zealand. Med. J. Aust. 182(12), 621–626 (2005).
  • Jindal SK. Hypoxemia and goals of oxygen therapy. In: Oxygen therapy. Jindal SK, Agarwal R (Eds). Jaypee Publications, New Delhi, India. 143–151 (2008).
  • Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Report of the Medical Research Council Working Party. Lancet 1(8222), 681–686 (1981).
  • Nocturnal Oxygen Therapy Trial Group. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Ann. Intern. Med. 93(3), 391–398 (1980).
  • Jindal SK. Oxygen therapy: important considerations. Indian J. Chest Dis. Allied Sci. 50(1), 97–107 (2008).
  • Semenza GL. Involvement of oxygen-sensing pathways in physiologic and pathologic erythropoiesis. Blood 114(10), 2015–2019 (2009).
  • Broström A, Hubbert L, Jakobsson P, Johansson P, Fridlund B, Dahlström U. Effects of long-term nocturnal oxygen treatment in patients with severe heart failure. J. Cardiovasc. Nurs. 20(6), 385–396 (2005).
  • Booth S, Kelly MJ, Cox NP, Adams L, Guz A. Does oxygen help dyspnea in patients with cancer? Am. J. Respir. Crit. Care Med. 153(5), 1515–1518 (1996).
  • Petty TL. Home oxygen therapy for COPD: practical aspects. Postgrad. Med. 69(4), 102–113 (1981).
  • Tarpy SP, Celli BR. Long-term oxygen therapy. N. Engl. J. Med. 333(11), 710–714 (1995).
  • Zielinski J, Tobiasz M, Hawrylkiewicz I, Sliwinski P, Palasiewicz G. Effects of long-term oxygen therapy on pulmonary hemodynamics in COPD patients: a 6-year prospective study. Chest 113(1), 65–70 (1998).
  • Petty TL. Supportive therapy in COPD. Chest 113(4 Suppl.), 256S–262S (1998).
  • Petty TL, Casaburi R. Recommendations of the Fifth Oxygen Consensus Conference. Writing and Organizing Committees. Respir. Care 45(8), 957–961 (2000).
  • Doherty DE, Petty TL, Bailey W et al. Recommendations of the 6th long-term oxygen therapy consensus conference. Respir. Care 51(5), 519–525 (2006).
  • Eaton T, Lewis C, Young P, Kennedy Y, Garrett JE, Kolbe J. Long-term oxygen therapy improves health-related quality of life. Respir. Med. 98(4), 285–293 (2004).
  • Chronos N, Adams L, Guz A. Effect of hyperoxia and hypoxia on exercise-induced breathlessness in normal subjects. Clin. Sci. 74(5), 531–537 (1988).
  • Lane R, Cockcroft A, Adams L, Guz A. Arterial oxygen saturation and breathlessness in patients with chronic obstructive airways disease. Clin. Sci. 72(6), 693–698 (1987).
  • Swinburn CR, Mould H, Stone TN, Corris PA, Gibson GJ. Symptomatic benefit of supplemental oxygen in hypoxemic patients with chronic lung disease. Am. Rev. Respir. Dis. 143(5 Pt 1), 913–915 (1991).
  • Cotes JE, Gilson JC. Effect of oxygen on exercise ability in chronic respiratory insufficiency; use of portable apparatus. Lancet 270(6928), 872–876 (1956).
  • Bradley BL, Garner AE, Billiu D, Mestas JM, Forman J. Oxygen-assisted exercise in chronic obstructive lung disease. The effect on exercise capacity and arterial blood gas tensions. Am. Rev. Respir. Dis. 118(2), 239–243 (1978).
  • Stein DA, Bradley BL, Miller WC. Mechanisms of oxygen effects on exercise in patients with chronic obstructive pulmonary disease. Chest 81(1), 6–10 (1982).
  • Somfay A, Porszasz J, Lee SM, Casaburi R. Dose-response effect of oxygen on hyperinflation and exercise endurance in nonhypoxaemic COPD patients. Eur. Respir. J. 18(1), 77–84 (2001).
  • Haidl P, Clement C, Wiese C, Dellweg D, Köhler D. Long-term oxygen therapy stops the natural decline of endurance in COPD patients with reversible hypercapnia. Respiration. 71(4), 342–347 (2004).
  • Kim V, Benditt JO, Wise RA, Sharafkhaneh A. Oxygen therapy in chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. 5(4), 513–518 (2008).
  • Weitzenblum E, Loiseau A, Hirth C, Mirhom R, Rasaholinjanahary J. Course of pulmonary hemodynamics in patients with chronic obstructive pulmonary disease. Chest 75(6), 656–662 (1979).
  • Oswald-Mammosser M, Weitzenblum E, Quoix E et al. Prognostic factors in COPD patients receiving long-term oxygen therapy. Importance of pulmonary artery pressure. Chest 107(5), 1193–1198 (1995).
  • Incalzi RA, Fuso L, De Rosa M et al. Electrocardiographic signs of chronic cor pulmonale: a negative prognostic finding in chronic obstructive pulmonary disease. Circulation 99(12), 1600–1605 (1999).
  • Kessler R, Faller M, Fourgaut G, Mennecier B, Weitzenblum E. Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 159(1), 158–164 (1999).
  • Weitzenblum E, Sautegeau A, Ehrhart M, Mammosser M, Pelletier A. Long-term oxygen therapy can reverse the progression of pulmonary hypertension in patients with chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 131(4), 493–498 (1985).
  • Timms RM, Khaja FU, Williams GW. Hemodynamic response to oxygen therapy in chronic obstructive pulmonary disease. Ann. Intern. Med. 102(1), 29–36 (1985).
  • Ikuma I, Ishibashi Y, Murakami Y et al. Improvement of right ventricular systolic performance by long-term domiciliary oxygen therapy in patients with chronic respiratory failure. Jpn. Circ. J. 53(7), 756–765 (1989).
  • Weitzenblum E, Oswald M, Mirhom R, Kessler R, Apprill M. Evolution of pulmonary haemodynamics in COLD patients under long-term oxygen therapy. Eur. Respir. J. Suppl. 7, 669s–673s (1989).
  • Cooper CB, Waterhouse J, Howard P. Twelve year clinical study of patients with hypoxic cor pulmonale given long term domiciliary oxygen therapy. Thorax 42(2), 105–110 (1987).
  • Sliwinski P. Effect of home oxygen therapy on patients with chronic obstructive lung diseases. Pneumonol. Alergol. Pol. 60(9–10), 20–27 (1992).
  • Prigatano GP, Parsons O, Wright E, Levin DC, Hawryluk G. Neuropsychological test performance in mildly hypoxemic patients with chronic obstructive pulmonary disease. J. Consult. Clin. Psychol. 51(1), 108–116 (1983).
  • Block AJ. Neuropsychological aspects of long-term oxygen therapy. Eur. J. Respir. Dis. Suppl. 146, 417–419 (1986).
  • Borak J, Sliwinski P, Tobiasz M, Górecka D, Zielinski J. Psychological status of COPD patients before and after one year of long-term oxygen therapy. Monaldi Arch. Chest Dis. 51(1), 7–11 (1996).
  • Hjalmarsen A, Waterloo K, Dahl A, Jorde R, Viitanen M. Effect of long-term oxygen therapy on cognitive and neurological dysfunction in chronic obstructive pulmonary disease. Eur. Neurol. 42(1), 27–35 (1999).
  • Wynne JW, Block AJ, Hemenway J, Hunt LA, Flick MR. Disordered breathing and oxygen desaturation during sleep in patients with chronic obstructive lung disease (COLD). Am. J. Med. 66(4), 573–579 (1979).
  • Calverley PM, Brezinova V, Douglas NJ, Catterall JR, Flenley DC. The effect of oxygenation on sleep quality in chronic bronchitis and emphysema. Am. Rev. Respir. Dis. 126(2), 206–210 (1982).
  • Fleetham J, West P, Mezon B, Conway W, Roth T, Kryger M. Sleep, arousals, and oxygen desaturation in chronic obstructive pulmonary disease. The effect of oxygen therapy. Am. Rev. Respir. Dis. 126(3), 429–433 (1982).
  • Krachman SL, Chatila W, Martin UJ et al.; National Emphysema Treatment Trial Research Group. Effects of lung volume reduction surgery on sleep quality and nocturnal gas exchange in patients with severe emphysema. Chest 128(5), 3221–3228 (2005).
  • Ringbaek TJ, Viskum K, Lange P. Does long-term oxygen therapy reduce hospitalisation in hypoxaemic chronic obstructive pulmonary disease? Eur. Respir. J. 20(1), 38–42 (2002).
  • Heaton RK, Grant I, McSweeny AJ, Adams KM, Petty TL. Psychologic effects of continuous and nocturnal oxygen therapy in hypoxemic chronic obstructive pulmonary disease. Arch. Intern. Med. 143(10), 1941–1947 (1983).
  • Okubadejo AA, Paul EA, Jones PW, Wedzicha JA. Does long-term oxygen therapy affect quality of life in patients with chronic obstructive pulmonary disease and severe hypoxaemia? Eur. Respir. J. 9(11), 2335–2339 (1996).
  • Eaton T, Garrett JE, Young P et al. Ambulatory oxygen improves quality of life of COPD patients: a randomised controlled study. Eur. Respir. J. 20(2), 306–312 (2002).
  • Tanni SE, Vale SA, Lopes PS, Guiotoko MM, Godoy I, Godoy I. Influence of the oxygen delivery system on the quality of life of patients with chronic hypoxemia. J. Bras. Pneumol. 33(2), 161–167 (2007).
  • Coleta KD, Lima DF, Tanni SE, Silveira LV, Godoy I, Godoy I. Gender and health status response to long-term oxygen therapy in COPD patients. Arch. Bronconeumol. 47(8), 382–388 (2011).
  • Fletcher EC, Luckett RA, Goodnight-White S, Miller CC, Qian W, Costarangos-Galarza C. A double-blind trial of nocturnal supplemental oxygen for sleep desaturation in patients with chronic obstructive pulmonary disease and a daytime PaO2 above 60 mmHg. Am. Rev. Respir. Dis. 145(5), 1070–1076 (1992).
  • Fletcher EC, Donner CF, Midgren B et al. Survival in COPD patients with a daytime PaO2 greater than 60 mmHg with and without nocturnal oxyhemoglobin desaturation. Chest 101(3), 649–655 (1992).
  • Górecka D, Gorzelak K, Sliwinski P, Tobiasz M, Zielinski J. Effect of long-term oxygen therapy on survival in patients with chronic obstructive pulmonary disease with moderate hypoxaemia. Thorax 52(8), 674–679 (1997).
  • Chaouat A, Weitzenblum E, Kessler R et al. A randomized trial of nocturnal oxygen therapy in chronic obstructive pulmonary disease patients. Eur. Respir. J. 14(5), 1002–1008 (1999).
  • Orth M, Walther JW, Yalzin S et al. Influence of nocturnal oxygen therapy on quality of life in patients with COPD and isolated sleep-related hypoxemia: a prospective, placebo-controlled cross-over trial. Pneumologie 62(1), 11–16 (2008).
  • Fletcher EC, Luckett RA, Miller T, Costarangos C, Kutka N, Fletcher JG. Pulmonary vascular hemodynamics in chronic lung disease patients with and without oxyhemoglobin desaturation during sleep. Chest 95(4), 757–764 (1989).
  • Levi-Valensi P, Weitzenblum E, Rida Z et al. Sleep-related oxygen desaturation and daytime pulmonary haemodynamics in COPD patients. Eur. Respir. J. 5(3), 301–307 (1992).
  • Chaouat A, Weitzenblum E, Kessler R et al. Sleep-related O2 desaturation and daytime pulmonary haemodynamics in COPD patients with mild hypoxaemia. Eur. Respir. J. 10(8), 1730–1735 (1997).
  • Chaouat A, Weitzenblum E, Kessler R et al. Outcome of COPD patients with mild daytime hypoxaemia with or without sleep-related oxygen desaturation. Eur. Respir. J. 17(5), 848–855 (2001).
  • Agarwal R, Jindal SK. Long-term oxygen therapy. In: Oxygen Therapy. Jindal SK, Agarwal R (Eds). Jaypee Publications, New Delhi, India. 193–210 (2008).
  • O’Driscoll BR. Short burst oxygen therapy in patients with COPD. Monaldi Arch. Chest Dis. 69(2), 70–74 (2008).
  • Woodcock AA, Gross ER, Geddes DM. Oxygen relieves breathlessness in ‘pink puffers’. Lancet 1(8226), 907–909 (1981).
  • Evans TW, Waterhouse JC, Carter A, Nicholl JF, Howard P. Short burst oxygen treatment for breathlessness in chronic obstructive airways disease. Thorax 41(8), 611–615 (1986).
  • McKeon JL, Murree-Allen K, Saunders NA. Effects of breathing supplemental oxygen before progressive exercise in patients with chronic obstructive lung disease. Thorax 43(1), 53–56 (1988).
  • Marques-Magallanes JA, Storer TW, Cooper CB. Treadmill exercise duration and dyspnea recovery time in chronic obstructive pulmonary disease: effects of oxygen breathing and repeated testing. Respir. Med. 92(5), 735–738 (1998).
  • Killen JW, Corris PA. A pragmatic assessment of the placement of oxygen when given for exercise induced dyspnoea. Thorax 55(7), 544–546 (2000).
  • Lewis CA, Eaton TE, Young P, Kolbe J. Short-burst oxygen immediately before and after exercise is ineffective in nonhypoxic COPD patients. Eur. Respir. J. 22(4), 584–588 (2003).
  • Nandi K, Smith AA, Crawford A et al. Oxygen supplementation before or after submaximal exercise in patients with chronic obstructive pulmonary disease. Thorax 58(8), 670–673 (2003).
  • Roberts CM. Short burst oxygen therapy for relief of breathlessness in COPD. Thorax 59(8), 638–640 (2004).
  • Stevenson NJ, Calverley PM. Effect of oxygen on recovery from maximal exercise in patients with chronic obstructive pulmonary disease. Thorax 59(8), 668–672 (2004).
  • O’Neill B, Bradley JM, Heaney L, O’Neill C, MacMahon J. Short burst oxygen therapy in chronic obstructive pulmonary disease: a patient survey and cost analysis. Int. J. Clin. Pract. 59(7), 751–753 (2005).
  • Eaton T, Fergusson W, Kolbe J, Lewis CA, West T. Short-burst oxygen therapy for COPD patients: a 6-month randomised, controlled study. Eur. Respir. J. 27(4), 697–704 (2006).
  • O’Neill B, Mahon JM, Bradley J. Short-burst oxygen therapy in chronic obstructive pulmonary disease. Respir. Med. 100(7), 1129–1138 (2006).
  • Quantrill SJ, White R, Crawford A et al. Short burst oxygen therapy after activities of daily living in the home in chronic obstructive pulmonary disease. Thorax 62(8), 702–705 (2007).
  • O’Driscoll BR, Neill J, Pulakal S, Turkington PM. A crossover study of short burst oxygen therapy (SBOT) for the relief of exercise-induced breathlessness in severe COPD. BMC Pulm. Med. 11, 23 (2011).
  • Soguel Schenkel N, Burdet L, de Muralt B, Fitting JW. Oxygen saturation during daily activities in chronic obstructive pulmonary disease. Eur. Respir. J. 9(12), 2584–2589 (1996).
  • Kawakami Y, Terai T, Yamamoto H, Murao M. Exercise and oxygen inhalation in relation to prognosis of chronic obstructive pulmonary disease. Chest 81(2), 182–188 (1982).
  • Takigawa N, Tada A, Soda R et al. Distance and oxygen desaturation in 6-min walk test predict prognosis in COPD patients. Respir. Med. 101(3), 561–567 (2007).
  • Casanova C, Cote C, Marin JM et al. Distance and oxygen desaturation during the 6-min walk test as predictors of long-term mortality in patients with COPD. Chest 134(4), 746–752 (2008).
  • Drummond MB, Blackford AL, Benditt JO et al.; NETT Investigators. Continuous oxygen use in nonhypoxemic emphysema patients identifies a high-risk subset of patients: retrospective analysis of the National Emphysema Treatment Trial. Chest 134(3), 497–506 (2008).
  • Bradley JM, Lasserson T, Elborn S, Macmahon J, O’Neill B. A systematic review of randomized controlled trials examining the short-term benefit of ambulatory oxygen in COPD. Chest 131(1), 278–285 (2007).
  • Nonoyama ML, Brooks D, Guyatt GH, Goldstein RS. Effect of oxygen on health quality of life in patients with chronic obstructive pulmonary disease with transient exertional hypoxemia. Am. J. Respir. Crit. Care Med. 176(4), 343–349 (2007).
  • Moore RP, Berlowitz DJ, Denehy L et al. A randomised trial of domiciliary, ambulatory oxygen in patients with COPD and dyspnoea but without resting hypoxaemia. Thorax 66(1), 32–37 (2011).
  • Wijkstra PJ, Guyatt GH, Ambrosino N et al. International approaches to the prescription of long-term oxygen therapy. Eur. Respir. J. 18(6), 909–913 (2001).
  • Cirio S, Nava S. Pilot study of a new device to titrate oxygen flow in hypoxic patients on long-term oxygen therapy. Respir. Care 56(4), 429–434 (2011).
  • Rice KL, Schmidt MF, Buan JS, Lebahn F, Schwarzock TK. AccuO2 oximetry-driven oxygen-conserving device versus fixed-dose oxygen devices in stable COPD patients. Respir. Care 56(12), 1901–1905 (2011).
  • Levi-Valensi P, Weitzenblum E, Pedinielli JL, Racineux JL, Duwoos H. Three-month follow-up of arterial blood gas determinations in candidates for long-term oxygen therapy. A multicentric study. Am. Rev. Respir. Dis. 133(4), 547–551 (1986).
  • Eaton TE, Grey C, Garrett JE. An evaluation of short-term oxygen therapy: the prescription of oxygen to patients with chronic lung disease hypoxic at discharge from hospital. Respir. Med. 95(7), 582–587 (2001).
  • Guyatt GH, Nonoyama M, Lacchetti C et al. A randomized trial of strategies for assessing eligibility for long-term domiciliary oxygen therapy. Am. J. Respir. Crit. Care Med. 172(5), 573–580 (2005).
  • O’Donohue WJ Jr, Plummer AL. Magnitude of usage and cost of home oxygen therapy in the United States. Chest 107(2), 301–302 (1995).
  • Croxton TL, Bailey WC. Long-term oxygen treatment in chronic obstructive pulmonary disease: recommendations for future research: an NHLBI workshop report. Am. J. Respir. Crit. Care Med. 174(4), 373–378 (2006).
  • Corrado A, Renda T, Bertini S. Long-term oxygen therapy in COPD: evidences and open questions of current indications. Monaldi Arch. Chest Dis. 73(1), 34–43 (2010).
  • Jindal SK, Agarwal R. Oxygen therapy for non-pulmonary disorders. In: Oxygen therapy. Jindal SK, Agarwal R (Eds). Jaypee Publications, New Delhi, India. 183–192 (2008).
  • Jindal SK. Oxygen therapy for pulmonary disorders. In: Oxygen therapy. Jindal SK, Agarwal R (Eds). Jaypee Publications, New Delhi, India. 157–182 (2008).
  • Crockett AJ, Alpers JH, Moss JR. Home oxygen therapy: an audit of survival. Aust. N. Z. J. Med. 21(2), 217–221 (1991).
  • Ström K, Boman G. Long-term oxygen therapy in parenchymal lung diseases: an analysis of survival. The Swedish Society of Chest Medicine. Eur. Respir. J. 6(9), 1264–1270 (1993).
  • Crockett AJ, Cranston JM, Antic N. Domiciliary oxygen for interstitial lung disease. Cochrane Database Syst. Rev. 3, CD002883 (2001).
  • Zielinski J. A nationwide system of long-term oxygen therapy: the Polish experience. Respir. Care 45(2), 231–235; discussion 235 (2000).
  • Zielinski J. Long-term oxygen therapy in conditions other than chronic obstructive pulmonary disease. Respir. Care 45(2), 172–176; discussion 176 (2000).
  • Behr J, Ryu JH. Pulmonary hypertension in interstitial lung disease. Eur. Respir. J. 31(6), 1357–1367 (2008).
  • Weitzenblum E, Chaouat A, Canuet M, Kessler R. Pulmonary hypertension in chronic obstructive pulmonary disease and interstitial lung diseases. Semin. Respir. Crit. Care Med. 30(4), 458–470 (2009).
  • Pitsiou G, Papakosta D, Bouros D. Pulmonary hypertension in idiopathic pulmonary fibrosis: a review. Respiration 82(3), 294–304 (2011).
  • Uronis HE, Abernethy AP. Oxygen for relief of dyspnea: what is the evidence? Curr. Opin. Support. Palliat. Care 2(2), 89–94 (2008).
  • Booth S, Wade R, Johnson M, Kite S, Swannick M, Anderson H; Expert Working Group of the Scientific Committee of the Association of Palliative Medicine. The use of oxygen in the palliation of breathlessness. A report of the expert working group of the Scientific Committee of the Association of Palliative Medicine. Respir. Med. 98(1), 66–77 (2004).
  • Stringer E, McParland C, Hernandez P. Physician practices for prescribing supplemental oxygen in the palliative care setting. J. Palliat. Care 20(4), 303–307 (2004).
  • Currow DC, Agar M, Smith J, Abernethy AP. Does palliative home oxygen improve dyspnoea? A consecutive cohort study. Palliat. Med. 23(4), 309–316 (2009).
  • Clemens KE, Quednau I, Klaschik E. Use of oxygen and opioids in the palliation of dyspnoea in hypoxic and non-hypoxic palliative care patients: a prospective study. Support. Care Cancer 17(4), 367–377 (2009).
  • Jaturapatporn D, Moran E, Obwanga C, Husain A. Patients’ experience of oxygen therapy and dyspnea: a qualitative study in home palliative care. Support. Care Cancer 18(6), 765–770 (2010).
  • Katsenos S, Charisis A, Daskalopoulos G, Constantopoulos SH, Vassiliou MP. Long-term oxygen therapy in chronic obstructive pulmonary disease: the use of concentrators and liquid oxygen systems in north-western Greece. Respiration. 73(6), 777–782 (2006).
  • Andersson A, Ström K, Brodin H et al. Domiciliary liquid oxygen versus concentrator treatment in chronic hypoxaemia: a cost-utility analysis. Eur. Respir. J. 12(6), 1284–1289 (1998).
  • Tiep B, Carter R. Oxygen conserving devices and methodologies. Chron. Respir. Dis. 5(2), 109–114 (2008).
  • Christopher KL, Schwartz MD. Transtracheal oxygen therapy. Chest 139(2), 435–440 (2011).
  • Sassoon CS, Hassell KT, Mahutte CK. Hyperoxic-induced hypercapnia in stable chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 135(4), 907–911 (1987).
  • Hanson CW 3rd, Marshall BE, Frasch HF, Marshall C. Causes of hypercarbia with oxygen therapy in patients with chronic obstructive pulmonary disease. Crit. Care Med. 24(1), 23–28 (1996).
  • Caruana-Montaldo B, Gleeson K, Zwillich CW. The control of breathing in clinical practice. Chest 117(1), 205–225 (2000).
  • Murabit A, Tredget EE. Review of burn injuries secondary to home oxygen. J. Burn Care Res. 33(2), 212–217 (2012).
  • Cullen DL. Long term oxygen therapy adherence and COPD: what we don’t know. Chron. Respir. Dis. 3(4), 217–222 (2006).
  • Vergeret J, Tunon De Lara M, Douvier JJ et al. Compliance of COPD patients with long term oxygen therapy. Eur. J. Respir. Dis. Suppl. 146, 421–425 (1986).
  • Prignot J. Home monitoring of patients on long-term oxygen therapy. Bull. Int. Union Tuberc. Lung Dis. 62(1–2), 33–34 (1987).
  • Desrues B, Lecoq C. Prescribing of long-term oxygen therapy and observation of its results. Rev. Mal. Respir. 6(3), 237–241 (1989).
  • Howard P, Waterhouse JC, Billings CG. Compliance with long-term oxygen therapy by concentrator. Eur. Respir. J. 5(1), 128–129 (1992).
  • Ström K, Boe J, Boman G, Midgren B, Rosenhall L. Long-term domiciliary oxygen therapy. Experiences acquired from the Swedish Oxygen Register. Monaldi Arch. Chest Dis. 48(5), 473–478 (1993).
  • Barjhoux C, Pépin JL, Deschaux-Blanc C et al. Long-term oxygen therapy at home. Compliance with the medical prescription and observance of the daily duration of at least 15 hours. Rev. Mal. Respir. 11(1), 37–45 (1994).
  • Díaz Lobato S, García Tejero MT, Villasante C. Patient compliance to the prescription of domiciliary oxygen therapy by transtracheal catheter. Arch. Bronconeumol. 32(4), 210–211 (1996).
  • Weitzenblum E. Observance of long-term oxygen therapy at home. Chest 109(5), 1135–1136 (1996).
  • Kampelmacher MJ, van Kestern RG, Alsbach GP et al. Characteristics and complaints of patients prescribed long-term oxygen therapy in The Netherlands. Respir. Med. 92(1), 70–75 (1998).
  • Peckham DG, McGibbon K, Tonkinson J, Plimbley G, Pantin C. Improvement in patient compliance with long-term oxygen therapy following formal assessment with training. Respir. Med. 92(10), 1203–1206 (1998).
  • Sampablo I, Escarrabill J, Rosell A, Manresa F, Estopá R. Transtracheal catheter acceptance and adverse events in long-term home oxygen therapy. Monaldi Arch. Chest Dis. 53(2), 123–126 (1998).
  • Avdeev SN, Aisanov ZR, Chuchalin AG. Compliance as a critical issue in long-term oxygen therapy. Monaldi Arch. Chest Dis. 54(1), 61–66 (1999).
  • Ringbaek T, Lange P, Viskum K. Compliance with LTOT and consumption of mobile oxygen. Respir. Med. 93(5), 333–337 (1999).
  • Oba Y, Salzman GA, Willsie SK. Reevaluation of continuous oxygen therapy after initial prescription in patients with chronic obstructive pulmonary disease. Respir. Care 45(4), 401–406 (2000).
  • Zinman C, Richards GA, Taylor R, Mer M. Long-term domiciliary oxygen therapy – the Johannesburg Hospital experience. S. Afr. Med. J. 90(6), 617–621 (2000).
  • Abdulla J, Pisinger C, Wennike PJ, Godtfredsen N, Tønnesen P. [Compliance of patients with chronic obstructive lung disease receiving oxygen therapy at home]. Ugeskr. Laeg. 163(42), 5824–5827 (2001).
  • Atis S, Tutluoglu B, Bugdayci R. Characteristics and compliance of patients receiving long-term oxygen therapy (LTOT) in Turkey. Monaldi Arch. Chest Dis. 56(2), 105–109 (2001).
  • Earnest MA. Explaining adherence to supplemental oxygen therapy: the patient’s perspective. J. Gen. Intern. Med. 17(10), 749–755 (2002).
  • Demirel H, Demir T, Umut S. Retrospective evaluation of patient compliance in continuous oxygen therapy. Respiration. 70(2), 149–153 (2003).
  • Ringbaek TJ. Continuous oxygen therapy for hypoxic pulmonary disease: guidelines, compliance and effects. Treat. Respir. Med. 4(6), 397–408 (2005).
  • Jiménez AL, López-Campos JL, Casas F et al. Factors related to variability in long-term oxygen therapy prevalence. Int. J. Tuberc. Lung Dis. 10(1), 110–114 (2006).
  • Lin SK, Kuna ST, Bogen DK. A novel device for measuring long-term oxygen therapy adherence: a preliminary validation. Respir. Care 51(3), 266–271 (2006).
  • Neri M, Melani AS, Miorelli AM et al.; Educational Study Group of the Italian Association of Hospital Pulmonologists (AIPO). Long-term oxygen therapy in chronic respiratory failure: a Multicenter Italian Study on Oxygen Therapy Adherence (MISOTA). Respir. Med. 100(5), 795–806 (2006).
  • Jones A, Wood-Baker R, Walters EH. Domiciliary oxygen therapy services in Tasmania: prescription, usage and impact of a specialist clinic. Med. J. Aust. 186(12), 632–634 (2007).
  • Lin SK, Bogen DK, Kuna ST. Validation of a novel device to objectively measure adherence to long-term oxygen therapy. Int. J. Chron. Obstruct. Pulmon. Dis. 3(3), 435–442 (2008).
  • Cullen DL, Stiffler D. Long-term oxygen therapy: review from the patients’ perspective. Chron. Respir. Dis. 6(3), 141–147 (2009).
  • Nasilowski J, Przybylowski T, Klimiuk J, Leskow A, Orska K, Chazan R. Effects of nurse home visits on compliance to long-term oxygen therapy. 14 months follow-up. Pneumonol. Alergol. Pol. 77(4), 363–370 (2009).
  • Rizzi M, Grassi M, Pecis M et al. A specific home care program improves the survival of patients with chronic obstructive pulmonary disease receiving long term oxygen therapy. Arch. Phys. Med. Rehabil. 90(3), 395–401 (2009).
  • Katsenos S, Constantopoulos SH. Long-term oxygen therapy in COPD: factors affecting and ways of improving patient compliance. Pulm. Med. 2011, 325362 (2011).
  • Marien H, Marchand E. Adherence to ambulatory oxygen therapy. Assessment and determinants in patients receiving long-term oxygen therapy. Rev. Mal. Respir. 28(7), 873–880 (2011).
  • Arnold E, Bruton A, Donovan-Hall M, Fenwick A, Dibb B, Walker E. Ambulatory oxygen: why do COPD patients not use their portable systems as prescribed? A qualitative study. BMC Pulm. Med. 11, 9 (2011).
  • Katsenos S, Froudarakis ME, Charisis A, Vassiliou MP, Constantopoulos SH. Long-term oxygen therapy in Ioannina. Respiration. 71(6), 619–624 (2004).
  • Zhu Z, Barnette RK, Fussell KM, Michael Rodriguez R, Canonico A, Light RW. Continuous oxygen monitoring – a better way to prescribe long-term oxygen therapy. Respir. Med. 99(11), 1386–1392 (2005).
  • Dunne PJ. The clinical impact of new long-term oxygen therapy technology. Respir. Care 54(8), 1100–1111 (2009).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.